Its Covid-19 vaccine and the antiviral pill will likely contribute a little over $12 billion to its top line, aligning with prior-year quarter's sales.
Its Covid-19 vaccine and the antiviral pill will likely contribute a little over $12 billion to its top line, aligning with prior-year quarter's sales.
Share this Article
Recommended